The clinical trial of a Russian COVID-19 vaccine being developed by the Siberian Vektor research center is due to be completed in September, the RIA news agency cited Russia’s healthcare watchdog as saying on Friday, Reuters reported.
Get in touch
Recent Posts
Most Popular
EBRD and EU Further Strengthen Cooperation Aimed at Supporting Ukraine
The EBRD and European Union are formalizing a pledge for the European Commission to provide assurances to support €70 million in recent EBRD loans...
Russian Hackers Launch Cyberattack on Ukraine’s DTEK
In retribution for its owner's resistance to Russia's war in Ukraine, Russian hackers launched a "cyberattack" on Ukraine's largest private energy conglomerate, the company...
Europe is Prepared if Russia Cuts Off Baltic States from Russian Power Grid
According to three sources with knowledge of the situation, if Moscow cuts off the Baltic states' access to the Russian grid, European grid operators...
Ukraine Starts with Electricity Export to the EU
According to President Volodymyr Zelenskyy, Ukraine has begun exporting electricity to the European Union, bringing in much-needed funds for the troubled nation and offering...
European Commission Authorizes Polish Fund for Companies Struck by Russian War in Ukraine
A Polish public assistance scheme of EUR 1.2 billion for businesses impacted by Russia's conflict against Ukraine has been authorized by the European Commission...